Results 131 to 140 of about 43,229 (277)
Ischemic colitis induced on the injection day of pegylated-interferon for persistently normal ALT
, 2011 青木 孝彦, 村田 一素, 斎藤 紘昭, Teppei Matsui, 伊藤 清顕, 今村 雅俊, Naohiko Masaki, Masanori Kobayashi, 青木 洋一郎, 尾上 淑子, 西村 崇, 矢田 智之, 吉澤 大, 小飯塚 仁彦, 上村 直実, 溝上 雅史 +15 moreopenalex +2 more sourcesInterferons in the treatment of myeloproliferative neoplasms
Therapeutic Advances in HematologyInterferons are cytokines with immunomodulatory properties and disease-modifying effects that have been used to treat myeloproliferative neoplasms (MPNs) for more than 35 years.Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M. Palmer, Aaron T. Gerds, Lucia Masarova, Andrew T. Kuykendall, Raajit K. Rampal, Ruben Mesa, Srdan Verstovsek +11 moredoaj +1 more sourcePsychosis during peginterferon-alpha2a and ribavirin therapy: case report
Brazilian Journal of Infectious DiseasesPegylated Interferon-alpha, combined with ribavirin, gives high sustained virological response in patients with hepatitis C virus, an important public health problem and one of the most frequent chronic infectious diseases worldwide.Lucas C. Quarantini, Simone Cunha Cruz, Susana Carolina Batista-Neves, Raymundo Paraná, Ângela Miranda-Scippa, Rodrigo A. Bressan +5 moredoaj +1 more sourceRetreatment with pegylated interferon plus ribavirin of chronic
hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. [PDF]
, 2009 BACKGROUND/AIMS: Efficacy of retreatment with pegylated interferon (PEG-IFN) plus ribavirin of non-responders to standard or pegylated IFN plus ribavirin has been assessed in various studies, but sustained virologic response (SVR) rates are variable and ...Andriulli, A., Attanasio, M., Bronte, F., Cabibbo, G., Camma', C., Craxi, A., Enea, M., Licata, A. +7 morecore Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency
, 2014 F. Rosina, Maria Elena Tosti, E. Borghesio, Maria Masocco, Alfonso Mele, Carmine Coppola, Michele Stanislaw Milella, Guglielmo Borgia, Pietro Andreoné, M. Koch, Anna Linda Zignego, Mario Romano, M. Carrara, Piero Luigi Almasio, E. Azzola, Gerardo Nardone, A. Benedetti, Giampiero Carosi, Francesco Mazzotta, Evangelista Sagnelli, Mario Rizzetto, M.C. Mascolo, C. Cursaro, A. Scuteri, J. Ranieri, M. Monti, S. Bellentani, A. Gasbarrini, M. Pompili, C. Puoti, L. Bellis, A. Regazzetti, E. Maffezzini, A. Pietrangelo, G. Abbati, G. Raimondo, L. Scribano, D. Martines, G. Svegliati Baroni, G. Faraci, S. Schianchi, G. Fornaciari, P. Fabris, S. Madonia, G. Civitavecchia, M. Pirisi, C. Smirne, A. Borghi, C. Sardini, M. Andreoletti, F. Morisco, N. Caporaso, S. Fargion, E. Fatta, F. Masutti, M.E. Bonaventura, A. Autolitano, M. Russello, A. Bellia, P. Toniutto, D. Bitetto, F. Mecenate, L. Pasulo, M.G. Lucà, A. Picardi, U. Vespasiani, I. Grattagliano, G. Palasciano, D. Romagno, C. Crespi, A. Gianstefani, G. Gobbo, V. Monti, G. Giannelli, N. Napoli, Nosotti, A. Raspanti, Cuccorese, A.E. Colombo, Floridia, M.S. Plattella, P. Cassano, I. Gentile, P.L. Blanc, V. Messina, S. Bonfante, P. Bellissima, M. Toti, J. Vecchiet, K. Falasca, V. Portelli, G. De Stefano, G. Pietromatera, P. Viganò, T. Re, M. Andreoni, G. Raineri, M. Massari, P.A. Grossi, S. Caputo +99 moreopenalex +2 more sourcesClinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients [PDF]
, 2009 Philippe Langlet, F D’Heygere, Jean Henrion, Michael Adler, Jean Delwaide, Hans Van Vlierberghe, Jean‐Pierre Mulkay, Luc Lasser, R Brenard, Yves Horsmans, P. Michielsen, Annick Laureys, Frederik Nevens +12 moreopenalex +1 more source
